Clinical trial
Phase II, Randomized, Double-blind Clinical Trial for Efficacy of G-CSF and Autologous Cord Blood Infusion in Children With Cerebral Palsy
NCT02866331 is registered in ClinicalTrials.gov with Hanyang University Seoul Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase II, Randomized, Double-blind Clinical Trial for Efficacy of G-CSF and Autologous Cord Blood Infusion in Children With Cerebral Palsy
- Lead sponsor
- Hanyang University Seoul Hospital
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- July 31, 2016
- Completion date
- December 31, 2018
- Enrollment
- 88 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.